Matching Design to Desire: Developing the Next Generation of Contraceptives
This blog is part of a series in partnership with Population Council, Reproductive Health Supplies Coalition (RHSC), and Population Services International (PSI), to recognize World Contraception [...]
The Dapivirine-Levonorgestrel Vaginal Ring for HIV Prevention and Contraception
The Issue Despite global efforts to reduce the number of new HIV infections to 500,000 by 2020, an estimated 1.3 million people became newly [...]
World Contraception Day 2023
Many young people still lack access to comprehensive sexuality education, experience bias when trying to obtain contraception, and are more likely to experience contraceptive failure. [...]
Are we investing in sexual and reproductive health products that people want to use?
On World Contraception Day, the importance of choice in the realm of sexual and reproductive health cannot be overstated Comprehensive sexual and reproductive health [...]
Food and Drug Administration (FDA) Approves the Nonprescription use of Opill
The Population Council congratulates the team behind the Opill development for achieving Food & Drug Administration approval of Opill, a progestin-only oral contraceptive, for [...]
New Ideas & Collective Guidance: An Overview of the 2023 International Committee for Contraception Research (ICCR) Meeting
The Population Council’s International Committee for Contraception Research (ICCR) welcomed a global consortium of clinical scientists, endocrinologists, gynecologists, and andrologists to discuss novel contraceptive [...]
Our Statement of Support for Over-the-Counter Access to a Progestin-only Pill
The Population Council believes that there is compelling effectiveness and safety data to support over-the-counter (OTC) status for oral contraception progestin-only pills (POP), such [...]
A Nestorone-Only Vaginal Ring for Contraception
Identifying gaps within current contraceptive options is essential to expanding access for all individuals. Currently, several contraceptives provide limited options for individuals with estrogen [...]